Tag: Biomedical Research Award

Rohidas Arote | Pharmaceutical Science | Biotechnology Advancement Award

Published on by WSA Awards

Prof. Rohidas Arote | Pharmaceutical Science | Biotechnology Advancement Award

Dr. Rohidas B. Arote is a distinguished professor in the Center for Nano and Material Sciences at Jain University, Bangalore, India. With over two decades of experience in biotechnology, gene therapy, and drug delivery, he has made substantial contributions to biomedical research. His expertise lies in biomaterials, pharmacology, toxicology, and theranostics, particularly in cancer, immune, and regenerative therapies. Having served as a professor at Seoul National University (SNU), a globally ranked institution, he has led groundbreaking research in non-viral gene delivery systems and targeted drug delivery for cancer therapy. Dr. Arote has secured major research grants, collaborated with international institutions, and delivered invited talks at global conferences. He has received prestigious awards such as the Creative Pioneering Research Award and IAAM Scientist Medal. In addition to his academic achievements, he actively contributes to international scientific societies, reviews for high-impact journals, and organizes leading scientific conferences. With a strong track record of publications, research funding, and innovation, Dr. Arote continues to be a key figure in biomedical and pharmaceutical sciences, advancing cutting-edge solutions for healthcare and drug development.

Professional Profile

Education

Dr. Rohidas B. Arote holds a Ph.D. in Biotechnology (2009) from Seoul National University, South Korea, where he specialized in gene therapy and drug delivery systems. His doctoral research focused on developing non-viral polymeric gene carriers for targeted cancer therapy. Before pursuing his Ph.D., he earned a Master of Science (M.S.) in Pharmacognosy and Phytochemistry (2002) from the University of Mumbai, India, where he gained expertise in natural product chemistry and pharmaceutical formulations. His academic journey began with a Bachelor of Science (B.S.) in Pharmaceutical Sciences (2000) from the University of Pune, India, equipping him with a strong foundation in pharmaceutics, drug formulation, and biotechnology. Throughout his education, he has been a recipient of several prestigious fellowships, including the Brain Korea (BK21) Fellowship (2008) and the Korea Science and Engineering Fellowship (KOSEF) (2005). He was also a GATE Scholar in Pharmacy (2000), a competitive national-level qualification exam conducted by IIT Kharagpur, India. His interdisciplinary academic background, spanning biotechnology, pharmaceutical sciences, and biomedical engineering, has enabled him to develop innovative solutions in gene therapy, biomaterials, and targeted drug delivery.

Professional Experience

Dr. Rohidas B. Arote has over 20 years of academic and research experience across prestigious institutions worldwide. He is currently a Professor at the Center for Nano and Material Sciences, Jain University, Bangalore (2021-present), where he leads cutting-edge research in nanomedicine and biomaterials. Prior to this, he served at Seoul National University (SNU), South Korea, as an Associate Professor (2017-2020) and Assistant Professor (2010-2017), where he developed gene delivery technologies for cancer therapy. He also worked as a Research Associate (2009-2010) at SNU, focusing on polymeric carriers for gene therapy. In addition, he held visiting professor positions at King Abdullah University of Science and Technology (KAUST), Saudi Arabia (2019-2020), and the Indian Institute of Science (IISc), Bangalore (2019-2020), contributing to advanced biomedical research. Early in his career, he gained industry experience as a Formulation & Development Scientist at Ajanta Pharma Ltd, Mumbai (2003-2004). His diverse academic, research, and industry experience has made him a leader in drug delivery, biomaterials, and biomedical engineering.

Research Interests

Dr. Rohidas B. Arote’s research focuses on gene therapy, drug delivery, biomaterials, biomedical engineering, pharmacology, toxicology, and theranostics. He is particularly interested in developing novel non-viral gene delivery systems for targeted cancer therapy. His work involves designing biodegradable polymeric nanocarriers for effective gene transfection, with applications in cancer, immune, and regenerative therapies. He explores nanotechnology-based drug delivery to enhance the bioavailability and therapeutic efficacy of pharmaceuticals. Additionally, he investigates biocompatible materials for tissue engineering and regenerative medicine, contributing to the development of next-generation biomaterials for medical applications. His interdisciplinary research bridges biotechnology, materials science, and pharmaceutical sciences, addressing critical challenges in disease treatment and drug delivery. Through collaborations with global research institutions, he continues to push the boundaries of biomedical research by integrating nanomedicine, molecular biology, and bioengineering to develop innovative therapeutic strategies.

Research Skills

Dr. Rohidas B. Arote possesses a diverse set of advanced research skills in biomedical and pharmaceutical sciences. He is an expert in nanotechnology-based drug delivery, specializing in the synthesis and characterization of biodegradable polymers for gene therapy applications. He has expertise in molecular biology techniques, including gene cloning, siRNA delivery, and CRISPR-based genome editing. His skills extend to polymeric biomaterials design, nanoparticle synthesis, and surface modification for targeted drug delivery. He is proficient in in vitro and in vivo models for evaluating gene expression, drug efficacy, and toxicity in preclinical studies. Additionally, he has experience in high-throughput screening, bioinformatics, and computational modeling for drug formulation optimization. His research involves the development of multifunctional polymeric carriers, receptor-mediated drug targeting, and biodegradable materials for regenerative medicine. His strong analytical and problem-solving abilities have enabled him to successfully secure research funding, publish in top-tier scientific journals, and contribute to cutting-edge biomedical innovations.

Awards and Honors

Dr. Rohidas B. Arote has received numerous prestigious awards for his pioneering research in gene therapy and biomaterials. He was honored with the Creative Pioneering Research Award (2017) from Seoul National University, recognizing his innovative contributions to biomedical research. He also received the IAAM Scientist Medal (2017) from the International Association of Advanced Materials, highlighting his excellence in advanced materials and nanomedicine. Other notable accolades include the Research Excellence Award (2010) from the Research Institute for Agriculture and Life Sciences and the Young Scientist Award (2008) from the 16th POLYCHAR: World Forum on Advanced Materials. He has been a Brain Korea (BK21) Fellow (2008) and received the Korea Science and Engineering Fellowship (KOSEF) (2005). His early academic achievements include being a GATE Scholar in Pharmacy (2000), a highly competitive national-level distinction. These awards reflect his outstanding research contributions, leadership in academia, and dedication to advancing biomedical sciences.

Conclusion

Dr. Rohidas B. Arote is an exceptional researcher and academic leader with a remarkable career spanning over two decades in biotechnology, gene therapy, and drug delivery. His contributions in biomaterials, nanomedicine, and regenerative therapies have significantly advanced the field of biomedical sciences. Through his research, funding acquisitions, and scientific collaborations, he has played a crucial role in developing novel drug delivery systems for cancer therapy. His achievements in securing high-impact publications, international awards, and research grants showcase his dedication to scientific excellence. In addition to his research, he has contributed as a peer reviewer, conference organizer, and mentor, shaping the next generation of biomedical researchers. As a professor at Jain University, Bangalore, and a former faculty member at Seoul National University, he continues to lead groundbreaking research in nanomedicine. With his strong academic background, innovative research, and global scientific impact, Dr. Arote stands as a deserving candidate for prestigious research awards, making a lasting impact in healthcare and pharmaceutical sciences.

Publications Top Notes

  1. Title: Microfluidics in Bioanalytical Chemistry
    Authors: R. Nisarga, P.P. Pandit, J.N. Sangshetti, R.B. Arote
    Year: Not provided

  2. Title: Exploring Antibiofilm Potential of Some New Imidazole Analogs Against C. Albicans: Synthesis, Antifungal Activity, Molecular Docking and Molecular Dynamics Studies
    Authors: S.K. Pathan, A.V. Shelar, S.U. Deshmukh, R.H. Patil, J.N. Sangshetti
    Year: 2023
    Citations: 1

  3. Title: In Silico Structure-Based Drug Design Approach to Find Potential Hits in Ventilator-Associated Pneumonia Caused by Pseudomonas aeruginosa
    Authors: M.G. Damale, R.B. Patil, S.A. Ansari, R.B. Arote, J.N. Sangshetti
    Year: 2022
    Citations: 2

  4. Title: Efficient Gene Transfection to Lung Cancer Cells via Folate-PEI-Sorbitol Gene Transporter
    Authors: K. Cho, S. Kim, H. Chun, A. Lee, R.B. Arote
    Year: 2022
    Citations: 6

  5. Title: Development of Novel, Biocompatible, Polyester Amines for Microglia-Targeting Gene Delivery
    Authors: B. Choi, M. Ahn, S. Hong, R.B. Arote, S.J. Lee
    Year: 2021
    Citations: 1

  6. Title: Insights of Tankyrases: A Novel Target for Drug Discovery
    Authors: M.G. Damale, S.K. Pathan, D.B. Shinde, R.B. Arote, J.N. Sangshetti
    Year: 2020
    Citations: 26

  7. Title: Boric Acid: A Versatile Catalyst in Organic Synthesis
    Authors: S.K. Pathan, P.R. Mahaparale, S.U. Deshmukh, R.B. Arote, J.N. Sangshetti
    Year: Not provided
    Citations: 5

Maria Lithoxopoulou | Health Professions | Best Researcher Award

Published on by WSA Awards

Assist. Prof. Dr. Maria Lithoxopoulou | Health Professions | Best Researcher Award

Neonatologist -Pediatrics at Faculty of Medicine Aristotle University of Thessaloniki, Greece

Dr. Maria Lithoxopoulou is an esteemed Assistant Professor of Paediatrics-Neonatology at Aristotle University of Thessaloniki, Greece. With over 17 years of clinical experience as a Consultant Neonatologist, she has made significant contributions to neonatal care, focusing on neonatal infections, retinopathy of prematurity, and neonatal nutrition. She holds a Ph.D. in Neonatal Infections and an MBA in Health Administration, showcasing a blend of clinical, research, and administrative expertise. Her research is widely recognized, with 27 published articles, 79 citations, and a Scopus h-index of 5. She has collaborated with various national and international researchers to improve neonatal healthcare outcomes. Her contributions extend beyond neonatology to include ophthalmology, pediatric nutrition, and maternal health, demonstrating a broad and interdisciplinary research approach. Dr. Lithoxopoulou is fluent in Greek and English, with strong technical skills in Microsoft Office and data analysis. Her dedication to academia and research makes her a key figure in advancing neonatal healthcare practices. She is committed to improving neonatal treatment protocols, optimizing drug delivery for preterm infants, and reducing neonatal complications through evidence-based research. With a passion for both clinical and academic excellence, she continues to impact neonatology and pediatrics significantly.

Professional Profile

Education

Dr. Maria Lithoxopoulou has a strong academic background in medicine and healthcare management. She earned her Degree in Medicine from Aristotle University of Thessaloniki, Faculty of Medicine, Greece, in 1994, which laid the foundation for her career in pediatrics and neonatology. She later obtained a License to Practice in Paediatrics in 2003, allowing her to specialize in neonatal care. To further advance her expertise, she pursued a Ph.D. in Neonatal Infections, focusing on Signal Transducer and Activator of Transcription in Neonatal Infection, which she completed in 2012 at Aristotle University of Thessaloniki. In addition to her medical training, she obtained an MBA in Health Administration (2017), which equipped her with the necessary skills to manage and lead healthcare units effectively. She later acquired a Medical Specialty in Neonatology after passing rigorous exams. Her multifaceted education combines clinical, research, and administrative expertise, enabling her to contribute significantly to neonatal medicine, hospital management, and academic research. Dr. Lithoxopoulou’s commitment to education and continuous learning has allowed her to excel in both research and patient care, making her a leading figure in the field of pediatric neonatology.

Professional Experience

Dr. Maria Lithoxopoulou has a distinguished career in neonatology, with extensive experience in both clinical practice and academic research. She began her professional journey as a Consultant Neonatologist at General Hospital of G. Papageorgiou, Aristotle University of Thessaloniki, where she served from 2005 to 2022. During her tenure, she played a critical role in treating preterm and critically ill newborns, optimizing neonatal care protocols, and improving neonatal survival rates. In 2022, she transitioned into academia as an Assistant Professor in Paediatrics-Neonatology at Aristotle University of Thessaloniki, where she continues to mentor medical students, supervise research projects, and contribute to cutting-edge neonatal research. Throughout her career, she has collaborated with multidisciplinary teams in pediatric healthcare, focusing on neonatal infections, retinopathy of prematurity, neonatal nutrition, and early neonatal sepsis management. Her expertise extends to hospital administration, research project management, and neonatal pharmacology, allowing her to bridge the gap between clinical care and medical research. Dr. Lithoxopoulou’s contributions have enhanced neonatal treatment protocols, improved screening techniques for neonatal diseases, and shaped the next generation of neonatologists and pediatricians. Her dedication to both patient care and scientific advancement makes her a leading expert in her field.

Research Interests

Dr. Maria Lithoxopoulou’s primary research interests lie in the field of neonatology, with a strong focus on neonatal infections, neonatal ophthalmology, and neonatal nutrition. She has conducted extensive research on retinopathy of prematurity (ROP), exploring innovative screening techniques, drug delivery methods, and treatment outcomes. Her work also delves into neonatal sepsis, thrombocytopenia, and the effects of maternal health on neonatal outcomes, providing valuable insights into early disease detection and intervention strategies. In addition, she has a growing interest in neonatal pharmacology, particularly in optimizing drug delivery methods for preterm infants to improve treatment efficacy. Dr. Lithoxopoulou is also involved in research concerning pediatric nutrition and the prevention of neonatal malnutrition, emphasizing the role of maternal education in child growth and development. Her interdisciplinary approach has led her to collaborate with researchers in ophthalmology, public health, and biomedical sciences, broadening the impact of her work beyond neonatology. She is committed to advancing evidence-based practices in neonatal care by developing new clinical guidelines, conducting systematic reviews, and engaging in large-scale neonatal health studies. Her research significantly contributes to improving neonatal healthcare standards worldwide.

Research Skills

Dr. Maria Lithoxopoulou possesses advanced research skills in neonatology, clinical trials, and medical data analysis. She has expertise in study design, statistical analysis, and systematic reviews, allowing her to conduct high-quality, evidence-based research. She is proficient in using Scopus, ORCID, and Google Scholar for literature review and citation tracking. Her research skills include quantitative and qualitative data analysis, with experience in handling clinical datasets and patient records to draw meaningful conclusions. She has conducted randomized controlled trials, observational studies, and meta-analyses, particularly in neonatal ophthalmology, neonatal pharmacology, and neonatal infections. Additionally, she is skilled in scientific writing and publishing, with 27 published papers in peer-reviewed journals. She collaborates with multidisciplinary research teams, contributing to studies that impact neonatal healthcare on a global scale. Dr. Lithoxopoulou is also adept at grant writing and securing research funding, helping to advance her work in neonatology. With strong skills in Microsoft Office, PowerPoint presentations, and online research tools, she effectively communicates her findings at national and international conferences. Her expertise in data interpretation and clinical application makes her a valuable asset to neonatal research and academic medicine.

Awards and Honors

Dr. Maria Lithoxopoulou has received recognition for her contributions to neonatology and medical research. She has been acknowledged for her work in neonatal ophthalmology, particularly in improving screening techniques for retinopathy of prematurity (ROP). Her research on neonatal infections and thrombocytopenia has been cited as influential in shaping clinical guidelines for neonatal care. Additionally, she has participated in several national and international research projects, earning grants and funding for her innovative studies. Her dedication to neonatology has also been recognized through invitations to speak at international conferences, where she has presented her findings on neonatal pharmacology, neonatal nutrition, and early disease detection in preterm infants. She has contributed to high-impact medical journals and has played a key role in collaborative neonatal research initiatives. While her h-index (5) and citation count (79) are growing, her research continues to gain recognition in the scientific community. Her commitment to advancing neonatal healthcare through cutting-edge research, academic leadership, and clinical excellence makes her a strong candidate for prestigious research awards in pediatrics and neonatology.

Conclusion

Dr. Maria Lithoxopoulou is a highly accomplished neonatologist and researcher with a strong academic background, extensive clinical experience, and a significant research portfolio. Her work in neonatal infections, ophthalmology, and nutrition has led to valuable advancements in neonatal care and treatment protocols. With 27 research publications, a growing citation impact, and numerous contributions to neonatal medicine, she is a leading expert in her field. While she continues to expand her research influence, her commitment to academia, clinical excellence, and medical innovation makes her an outstanding candidate for the Best Researcher Award.

Publications Top Notes

  • Determination of macronutrient profile and energy composition in human milk via Mid‐Infrared Spectrometer Analysis: An experimental study

    • Authors: Maria Lithoxopoulou, Anastasia Gkampeta, Dimitrios Rallis, Katerina Tzafilkou, Eftychia Drogouti, Christos Tsakalidis
    • Year: 2025

  • A hydrophilic interaction liquid chromatography – Tandem mass spectrometry method for the determination of phenylephrine in dried blood spots from preterm infants

    • Authors: E. Boutou, C. Virgiliou, A.K. Seliniotaki, M. Lithoxopoulou, A. Mataftsi, N. Ziakas, E. Diamanti, N. Raikos, H. Gika
    • Year: 2022

  • Avoiding use of lid speculum and indentation reduced infantile stress during retinopathy of prematurity examinations

    • Authors: A. Mataftsi, M. Lithoxopoulou, A.K. Seliniotaki, P. Talimtzi, E. Oustoglou, E. Diamanti, V. Soubasi, N. Ziakas, A.-B. Haidich
    • Year: 2022

  • Population-Based Studies in Retinopathy of Prematurity and Screening Criteria Used

    • Authors: Stella Moutzouri, Aikaterini K. Seliniotaki, Maria Lithoxopoulou, Anna-Bettina Haidich, Nikolaos Ziakas, Asimina Mataftsi
    • Year: 2022

  • Clinical chorioamnionitis and histologic placental inflammation: association with early-neonatal sepsis

    • Authors: D. Rallis, M. Lithoxopoulou, S. Pervana, P. Karagianni, I. Hatziioannidis, V. Soubasi, C. Tsakalidis
    • Year: 2021

  • Efficacy and safety of mydriatic microdrops for retinopathy of prematurity screening: an external pilot crossover randomized controlled trial

    • Authors: A.K. Seliniotaki, M. Lithoxopoulou, P. Talimtzi, E. Georgiou, E. Diamanti, N. Ziakas, A.-B. Haidich, A. Mataftsi
    • Year: 2021

  • Potential benefit from the implementation of the Kaiser Permanente neonatal early-onset sepsis calculator on clinical management of neonates with presumed sepsis

    • Authors: I. Kopsidas, N.-M. Molocha, E. Kourkouni, S. Coffin, D. Gkentzi, E. Chorianopoulou, G. Dimitriou, A. Kapetanaki, G. Karavana, M. Lithoxopoulou, et al.
    • Year: 2021

  • Reducing duration of antibiotic use for presumed neonatal early-onset sepsis in Greek NICUs: A “low-hanging fruit” approach

    • Authors: I. Kopsidas, G.-C. Tsopela, N.-M. Molocha, E. Bouza, E. Chorafa, E. Chorianopoulou, V. Giapros, D. Gkentzi, T. Gkouvas, A. Kapetanaki, et al.
    • Year: 2021

  • A neonate with intrauterine growth restriction and pseudo-Bartter syndrome due to severe maternal eating disorder: A case report

    • Authors: E. Babatseva, I. Chatziioannidis, A.A. Tagaraki, D. Tramma, K. Dampala, E. Chatzitoliou, E. Papacharalambous, G. Mitsiakos, C. Tsakalidis, P. Karagianni, et al.
    • Year: 2020

  • Alternative mydriasis techniques for retinopathy of prematurity screening

    • Authors: A.K. Seliniotaki, E. Prousali, M. Lithoxopoulou, S. Kokkali, N. Ziakas, V. Soubasi, A. Mataftsi
    • Year: 2020

 

Wei Zhang | Health Professions | Best Researcher Award

Published on by WSA Awards

Prof. Dr. Wei Zhang | Health Professions | Best Researcher Award

Professor at School of Nursing, Jilin University, China

Dr. Zhang Wei is a distinguished professor at Jilin University’s School of Nursing, where she leads the Department of Obstetrics and Gynecology Nursing. Her extensive career encompasses significant contributions to maternal and child health nursing, mental health nursing, and nursing education. Dr. Zhang has published over 40 papers as the first or corresponding author, with more than 30 in SCI-indexed journals, underscoring her commitment to advancing nursing science.

Professional Profile

Education

Dr. Zhang’s academic journey began with a bachelor’s degree in Maternal and Child Health from Jilin University’s Norman Bethune College of Medicine in 2002. She then earned a master’s degree in Women’s Health from the same institution in 2005. Pursuing further specialization, she obtained her Ph.D. in Immunology from Jilin University’s First Hospital in 2012. Demonstrating a commitment to interdisciplinary research, Dr. Zhang completed a postdoctoral fellowship in Social Medicine and Health Management at Jilin University’s School of Public Health between 2015 and 2021.

Professional Experience

Dr. Zhang’s professional trajectory at Jilin University is marked by progressive academic appointments. She began as a teaching assistant in the School of Nursing in 2005, advanced to lecturer in 2008, and was promoted to associate professor in 2014. In September 2023, she achieved the rank of professor. Throughout her tenure, Dr. Zhang has been instrumental in curriculum development and has served on both the Academic and Teaching Committees of the School of Nursing.

Research Interests

Dr. Zhang’s research interests are diverse and impactful. She focuses on maternal and child health nursing, emphasizing health promotion and care for women during critical life stages such as pregnancy, perimenopause, and adolescence. Her work in mental health nursing addresses psychological well-being, while her studies in chronic disease management concentrate on nursing care and preventive measures for female reproductive system cancers, including breast and gynecological tumors. Additionally, Dr. Zhang is dedicated to nursing education, exploring innovative teaching models and methods, particularly in blended learning environments.

Research Skills

Dr. Zhang possesses a robust set of research skills, including proficiency in systematic reviews and meta-analyses, as evidenced by her publications on topics like the effectiveness of family-centered interventions for caregivers and internet-based cognitive behavioral therapy for cancer patients. She is adept at both qualitative and quantitative research methodologies, enabling her to conduct comprehensive studies that inform evidence-based nursing practices.

Awards and Honors

Throughout her career, Dr. Zhang has received numerous accolades recognizing her contributions to nursing education and research. Notably, she was awarded the third prize in the 17th Jilin Province Higher Education Scientific Research Achievement Awards in November 2022 for her work on blended teaching models in obstetrics and gynecology nursing. She also received the Excellence Award for Undergraduate “Classroom Teaching Quality” at Jilin University for the 2021-2022 academic year, reflecting her dedication to teaching excellence.

Conclusion

Dr. Zhang Wei’s exemplary career in nursing is characterized by her unwavering commitment to advancing healthcare through research, education, and leadership. Her multidisciplinary expertise and dedication to improving women’s health have significantly impacted both the academic community and clinical practice. Dr. Zhang continues to inspire future generations of nurses and healthcare professionals through her innovative work and steadfast dedication to the field.

Publication Top Notes

  1. “Effectiveness of Meaning-Centered Interventions on Existential Distress and Mental Health Outcomes in Cancer Survivors and Their Family Caregivers: A Systematic Review and Meta-Analysis of Randomized Controlled Trials”
    • Authors: Ziqi Wang, Dongsheng Xu, Shuanghan Yu, Yantong Liu, Yujie Han, Wei Zhao, Wei Zhang
    • Year: 2025
    • Journal: Worldviews on Evidence-Based Nursing
  2. “Effects of Nurse-Led e-Health Interventions on the Health-Related Outcomes of Pregnant Women: A Systematic Review”
    • Authors: Yujie Han, Qi Tian, Mengmeng Xu, Ziqi Wang, Wei Zhang
    • Year: 2025
    • Journal: Journal of Clinical Nursing
  3. “The Impact of Simulation-Based Learning on Nursing Decision-Making Ability: A Meta-Analysis”
    • Authors: Wei Zhao, Mengmeng Xu, Qi Tian, Ziqi Wang, Wei Zhang
    • Year: 2024
    • Journal: Clinical Simulation in Nursing
  4. “Effectiveness of Family-Centered Interventions for Family Caregivers: A Systematic Review and Meta-Analysis of Randomized Controlled Trials”
    • Authors: Ziqi Wang, Shuanghan Yu, Yantong Liu, Yujie Han, Wei Zhao, Wei Zhang
    • Year: 2024
    • Journal: Journal of Clinical Nursing
    • Citations: 2

 

Shibo Cheng | Translational Medicine | Best Researcher Award

Published on by WSA Awards

Assoc. Prof. Dr. Shibo Cheng | Translational Medicine | Best Researcher Award

School of Laboratory Medicine at Hubei University of Chinese Medicine, China

Dr. Shi-Bo Cheng, an accomplished researcher in Analytical Chemistry, is currently an Associate Professor at the School of Laboratory Medicine, Hubei University of Chinese Medicine. His academic journey has been characterized by a focus on developing novel molecular diagnostic technologies through interdisciplinary collaboration. With expertise spanning nanomaterials, microfluidics, and machine learning, Dr. Cheng has made significant advancements in bioanalysis and translational medicine. His contributions have been documented in over 16 high-impact publications in prestigious journals, addressing critical challenges in disease diagnosis and personalized medicine. His patents further reflect his dedication to bridging the gap between innovation and practical applications. Dr. Cheng’s career progression from postdoctoral research at renowned U.S. institutions to an academic leadership role in China highlights his global expertise and commitment to advancing science.

Professional Profile

Education

Dr. Cheng completed his Ph.D. in Analytical Chemistry from Wuhan University (2014–2019), a premier institution in China, under the mentorship of Prof. Wei-Hua Huang. His doctoral research laid the foundation for his expertise in bioanalysis, particularly in developing advanced diagnostic tools for diseases. Prior to this, he earned a Bachelor’s degree in Chemistry from the same institution (2010–2014), gaining a strong foundation in analytical methodologies and laboratory techniques. His education reflects rigorous training and a focus on innovation in analytical sciences.

Professional Experience

Dr. Cheng’s professional journey reflects steady growth and contributions to cutting-edge research. From 2020 to 2024, he served as a postdoctoral researcher in the Department of Chemistry at the University of Florida and the University of Kansas, where he engaged in advanced studies on extracellular vesicle analysis and cancer diagnostics. In 2024, he joined Hubei University of Chinese Medicine as an Associate Professor, where he continues to lead research initiatives in bioanalysis. His experience showcases a blend of academic excellence and practical innovation across global research environments.

Research Interests

Dr. Cheng’s research focuses on bioanalysis and translational medicine, with an emphasis on developing advanced molecular diagnostic technologies. His interests lie in using nanomaterials and microfluidic systems to analyze disease biomarkers such as circulating tumor cells, extracellular vesicles, and proteins. Furthermore, he integrates machine learning into diagnostic model construction for applications in clinical diagnostics, personalized medicine, and dynamic treatment monitoring. Dr. Cheng’s interdisciplinary approach aims to address pressing medical challenges and improve patient outcomes.

Research Skills

Dr. Cheng possesses exceptional skills in nanomaterial synthesis, microfluidic device fabrication, and advanced bioanalytical techniques. He is proficient in designing and implementing innovative diagnostic platforms, particularly for disease biomarker analysis. His expertise extends to employing machine learning algorithms for constructing diagnostic models, bridging the gap between analytical chemistry and computational biology. With hands-on experience in electrochemical detection, extracellular vesicle analysis, and circulating tumor cell isolation, Dr. Cheng’s research skills exemplify his innovative and multidisciplinary approach to solving complex biomedical problems.

Awards and Honors

Dr. Cheng’s contributions to research have been recognized through his publications in high-impact journals and his leadership in securing three innovative patents. These patents reflect his ability to translate scientific discoveries into practical applications. Additionally, his appointment as Associate Professor at Hubei University of Chinese Medicine signifies recognition of his expertise and impact. While specific awards are not highlighted, his consistent research output and career advancements underscore his status as a distinguished researcher in his field.

Conclusion

Dr. Shi-Bo Cheng is a trailblazing researcher whose work bridges chemistry, biology, and engineering to tackle critical challenges in medical diagnostics. His innovative contributions in bioanalysis, supported by his educational background and professional experience, demonstrate his commitment to advancing science for societal benefit. With a proven track record of impactful research and practical innovations, Dr. Cheng is well-positioned as a leader in his field and a strong contender for the Best Researcher Award.

Publication Top Notes

  • Title: Dual Gold Nanostructures-Based Stretchable Electrochemiluminescence Sensors for Hydrogen Peroxide Monitoring in Endothelial Mechanotransduction
    Authors: Liu, H., Wang, Q., Cheng, S.-B., Huang, W.-H., Chen, M.-M.
    Year: 2024
  • Title: Intravascular elimination of circulating tumor cells and cascaded embolization with multifunctional 3D tubular scaffolds
    Authors: Chen, Y., Li, C., Yang, J., Yuan, G., Xie, M.
    Year: 2024
  • Title: Metal-organic framework-interfaced ELISA probe enables ultrasensitive detection of extracellular vesicle biomarkers
    Authors: Shi, J., Barman, S.C., Cheng, S., Zeng, Y.
    Year: 2024
    Citations: 2
  • Title: Hydromechanical Modulation of Enzymatic Kinetics Using Microfluidically Configurable Nanoconfinement Arrays
    Authors: Wen, Y., Li, Y., Chu, H.C.W., Cheng, S., Zeng, Y.
    Year: 2024
  • Title: Lineage specific extracellular vesicle-associated protein biomarkers for the early detection of high grade serous ovarian cancer
    Authors: Trinidad, C.V., Pathak, H.B., Cheng, S., Zeng, Y., Godwin, A.K.
    Year: 2023
    Citations: 4
  • Title: Reversible capture and release of circulating tumor cells on a three-dimensional conductive interface to improve cell purity for gene mutation analysis
    Authors: Wang, Y.-K., Wang, M., Cheng, S.-B., Xie, M., Huang, W.-H.
    Year: 2023
    Citations: 3
  • Title: Advances in microfluidic extracellular vesicle analysis for cancer diagnostics
    Authors: Cheng, S., Li, Y., Yan, H., Friedman, L., Zeng, Y.
    Year: 2021
    Citations: 49
  • Title: A Stretchable Scaffold with Electrochemical Sensing for 3D Culture, Mechanical Loading, and Real-Time Monitoring of Cells
    Authors: Qin, Y., Hu, X.-B., Fan, W.-T., Liu, Y.-L., Huang, W.-H.
    Year: 2021
    Citations: 21
  • Title: A Three-Dimensional Conductive Scaffold Microchip for Effective Capture and Recovery of Circulating Tumor Cells with High Purity
    Authors: Cheng, S.-B., Chen, M.-M., Wang, Y.-K., Xie, M., Huang, W.-H.
    Year: 2021
    Citations: 25
  • Title: Advances in Analytical Technologies for Extracellular Vesicles
    Authors: Yan, H., Li, Y., Cheng, S., Zeng, Y.
    Year: 2021
    Citations: 66

 

 

 

Mohammadkian Zarafshani | Medicine and Dentistry | Best Researcher Award

Published on by WSA Awards

Dr. Mohammadkian Zarafshani | Medicine and Dentistry | Best Researcher Award

Rheumatology at Tehran University of Medical Sciences, Iran

Dr. Mohammadkian Zarafshani is a dedicated physician and researcher with a robust foundation in clinical and basic medical sciences. With extensive experience in patient care and research, he has demonstrated excellence in managing projects and publishing findings in esteemed journals and conferences. His work spans multiple fields, including surgery, rheumatology, and oncology, reflecting his versatility and commitment to advancing medical knowledge. As a peer reviewer for several prestigious journals, he contributes significantly to the scientific community by ensuring high-quality research dissemination. His passion for integrating clinical practice with research has led to impactful discoveries, particularly in endoplasmic reticulum stress pathways and their role in colorectal cancer. Dr. Zarafshani is recognized for his effective communication, leadership, and problem-solving skills, which complement his medical expertise.

Professional Profile

Education

Dr. Zarafshani earned his Doctor of Medicine (MD) degree from Kermanshah University of Medical Sciences, Iran, in 2021. His academic journey was marked by a distinguished thesis conducted at the Cancer Biology Research Center, Tehran University of Medical Sciences, focusing on the XBP1s factor as an ER stress pathway indicator in colorectal cancer patients. This research highlighted his ability to bridge clinical observations with molecular insights. His educational achievements, coupled with active participation in conferences and research committees, laid a strong foundation for his ongoing contributions to medical science.

Professional Experience

Dr. Zarafshani serves as a physician and researcher at Bistoon Private Hospital’s Department of Surgery in Kermanshah, Iran, since 2021. His role involves patient care and clinical research, reflecting his ability to blend practical expertise with investigative pursuits. During his military service from 2021 to 2023, he worked as a physician and researcher at the Rheumatology Research Center, Shariati Hospital, Tehran University of Medical Sciences, conducting impactful studies in rheumatology. His previous engagements include supervising research projects and assisting in studies on colorectal cancer and pediatric Behçet’s disease. Dr. Zarafshani’s career highlights his commitment to clinical excellence and advancing medical research.

Research Interests

Dr. Zarafshani’s research interests encompass surgery, oncology, and rheumatology, with a particular focus on understanding molecular mechanisms underlying diseases. His notable work includes exploring the IRE1/XBP1s pathway in colorectal cancer and investigating genetic factors influencing autoimmune conditions. He is deeply committed to translating basic research into clinical applications, enhancing patient outcomes through innovative therapeutic approaches. Dr. Zarafshani is also intrigued by the psychosocial aspects of healthcare, evident in his studies on communication between students and professors and the mental health benefits of cultural practices like Quran memorization.

Research Skills

Dr. Zarafshani possesses advanced research skills, including clinical data collection, statistical analysis, and laboratory techniques like PCR and immunohistochemistry (IHC). He excels in medical writing and manuscript preparation, contributing as an active journal reviewer for Clinical Case Reports, PLOS One, and the International Journal of Surgery Case Reports. His expertise extends to capillaroscopy and other diagnostic methods, enhancing his capability to conduct comprehensive clinical research. Dr. Zarafshani’s ability to lead multidisciplinary teams and address complex problems underscores his proficiency in collaborative and independent research.

Awards and Honors

Dr. Zarafshani has received numerous accolades for his contributions to medical research and education. He was recognized by the Chairman of Kermanshah University of Medical Sciences for outstanding presentations during Health Week in 2015 and 2016. He earned the Best Paper Award as a panelist at Shahid Beheshti University of Medical Sciences in 2015. Additionally, he was honored as an exceptional researcher by the Vice Chancellor of Kermanshah University of Medical Sciences in 2015. These achievements reflect his dedication to excellence in research, education, and clinical practice.

Conclusion 💡

Dr. Mohammadkian Zarafshani is a highly accomplished researcher with a robust portfolio in clinical and molecular research. His ability to bridge basic and applied research, coupled with strong academic credentials and recognized contributions, makes him a competitive candidate for the Best Researcher Award.

Publication Top Notes

  1. Zarafshani M, Avateffazeli M, Moeini Taba SM, Faghihi R, Beikmohamadi Hezaveh S, Ziaee V, Tahghighi F, Loghman M
    Misdiagnosed for 14 Years: Adenosine deaminase 2 (ADA2) Deficiency in a Teen Mimicking Polyarteritis Nodosa.
    Clinical Case Reports Journal, 2024, November 24.
  2. Zarafshani M, Rahmanian E, Manouchehri Ardekani R, Hassan Matini SA, Loghman M, Faezi ST
    Concomitant manifestations of systemic lupus erythematosus flare-up and nodal marginal zone B-cell lymphoma in a 41-year-old male patient: A challenging case report.
    Clinical Case Reports Journal, 2024, August 19; 12(8):e9337.
  3. Zarafshani M, Mahmoodzadeh H, Soleimani V, Moosavi MA, Rahmati M
    Expression and Clinical Significance of IRE1-XBP1s, p62, and Caspase-3 in Colorectal Cancer Patients.
    Iranian Journal of Medical Sciences, 2024, January 1; 49(1):10-21.
  4. Fattahi MR, Zarafshani M, Abdolahad M, Jalaeefar A, Mahdavi R, Yousefpour N, Saffar H, Mousavi‐Kiasary SM, Pakdel F
    Intraoperative use of electrical impedance spectroscopy for adenoid cystic carcinoma of the lacrimal gland: A case report.
    Clinical Case Reports, 2023, October; 11(10):e7995.
  5. Mozafar M, Mohebbi H, Parvas E, Sakhaei D, Zarafshani M, Ilkhani S
    Superior mesenteric artery thrombosis with concomitant pancreaticoduodenal artery pseudoaneurysm in a 60-year-old male patient—A case report.
    International Journal of Surgery Case Reports, 2023, August 1; 109:108622.
  6. Zarafshani M, Loghman M, Hakemi MS, Nili F, Hezaveh SB, Nejad MT, Faezi ST
    IgM nephropathy in a patient with dermatomyositis following COVID‐19 vaccination: A case report.
    International Journal of Rheumatic Diseases, 2023, July 11.
  7. Zarafshani M, Sharafi L, Athari Z
    The Investigate Students’ Motivation to Communicate Teacher-Students in Kermanshah University of Medical Sciences in 2016-17.
    Education Strategies in Medical Sciences, 2019, March 10; 11(6):1-1.
  8. Zarafshani MK, Shahmohammadi A, Vaisi-Raygani A, Bashiri H, Yari K
    Association of interleukin-8 polymorphism (+781 C/T) with the risk of ovarian cancer.
    Meta Gene, 2018, June 1; 16:165-9.
  9. Zarafshani MK, Rezaee AM, Zarafshani G
    Comparing the indicators of general health among two groups of female Quran memorizers and non-memorizers in Kermanshah, Iran.
    Journal of Research on Religion & Health, 2017, January 1; 3(2):43-52.

 

 

Jasmine Naru | CANCER PROTEOMICS | Women Researcher Award

Published on by WSA Awards

Dr. Jasmine Naru | CANCER PROTEOMICS | Women Researcher Award

Staff Scientist at Fred Hutch Cancer Center, United States

Jasmine Naru is a dedicated biological researcher with a robust background in various biological disciplines, including proteomics, molecular biology, biochemistry, and genetics. She earned her Ph.D. in Biochemistry from Panjab University, India, in 2016, and has since been associated with prestigious research institutions. Currently a Staff Scientist at the Fred Hutchinson Cancer Center in Seattle, WA, Jasmine has contributed significantly to the field of cancer research, particularly focusing on acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS). Her innovative research approaches aim to enhance risk stratification and therapeutic targeting for these conditions. Jasmine’s work has resulted in multiple publications in high-impact journals, showcasing her expertise and commitment to advancing the understanding of cancer biology.

Professional Profile

Education

Jasmine Naru’s educational journey reflects her commitment to biological research and academic excellence. She completed her Bachelor of Science in Life Sciences with a focus on Zoology, Botany, and Chemistry at Guru Nanak Dev University in 2006. She pursued her Master of Science in Human Genetics, graduating in 2008 from the same institution. Jasmine then advanced her studies at Panjab University, where she earned her Ph.D. in Biochemistry in 2016. Her doctoral research focused on protein profiling in retinoblastoma patients, utilizing mass spectrometry-based proteomics to identify potential biomarkers. This solid educational foundation has equipped her with the necessary knowledge and skills to excel in her research endeavors.

Professional Experience

Jasmine Naru has gained extensive professional experience in the field of biological research. She began her career as a Junior Research Fellow at the Post Graduate Institute of Medical Education and Research (PGIMER) in India in 2010. Her journey continued at Panjab University, where she served as a Junior and Senior Research Fellow until 2016. Following her academic tenure, Jasmine transitioned to the Fred Hutchinson Cancer Center in Seattle as a Postdoctoral Research Fellow, focusing on innovative cancer research projects from 2017 to 2023. Recently, she has taken on the role of Staff Scientist at Fred Hutch, where she develops novel approaches for risk stratification and therapeutic targeting in AML and MDS. Her professional trajectory showcases her dedication to advancing cancer research and her ability to lead impactful projects.

Research Interests

Jasmine Naru’s research interests are centered on advancing the understanding of hematological malignancies, particularly acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS). She focuses on the development of innovative strategies for risk stratification and targeted therapy, employing proteomic and genomic approaches to identify novel biomarkers that can enhance patient outcomes. Her work encompasses the use of iPSC-derived cell lines to explore the biology of MDS and the development of immunotherapy techniques for myeloid malignancies. Jasmine is passionate about translating her research findings into clinical applications that can significantly improve the lives of patients facing these challenging diseases, making her a valuable contributor to the field of cancer research.

Research Skills

Jasmine Naru possesses a comprehensive set of research skills that enhance her capabilities as a biological researcher. Her technical proficiency includes advanced techniques in proteomics, such as mass spectrometry (ESI-MS/MS, MALDI-TOF/TOF), as well as quantitative analysis methods like iTRAQ and TMT. Jasmine is adept at using bioinformatics tools for pathway analysis and has experience in various molecular biology techniques, including PCR, ELISA, Western blotting, and flow cytometry. Additionally, she has strong analytical skills, enabling her to interpret complex data effectively. Jasmine’s multitasking abilities and collaborative approach allow her to thrive in fast-paced research environments, making her an asset to any scientific team.

Awards and Honors

Throughout her academic and professional career, Jasmine Naru has received several honors and recognitions for her contributions to the field of biological research. Notably, she was awarded the Junior Research Fellowship from the Indian Council of Medical Education and Research (ICMR) during her early research career, which provided her with essential support to pursue her doctoral studies. Her commitment to excellence is reflected in her successful publication record, with multiple first-author articles in high-impact journals. Jasmine’s research efforts have also been acknowledged through various project grants, such as the SWOG Impact Award and NIH/NIDDK funding, highlighting her contributions to advancing cancer research and her potential for future impactful work.

Conclusion

Overall, Jasmine Naru is a strong candidate for the Best Researcher Award. Her exceptional research experience in oncology, strong technical skills, and noteworthy publication record make her a highly deserving contender. Expanding her work’s breadth and obtaining more independent funding could further solidify her position as a top researcher in her field. Her dedication and scientific contributions already position her as a standout researcher with a clear impact in the scientific community.

Publication Top Note

  1. Verification of prognostic expression biomarkers is improved by examining enriched leukemic blasts rather than mononuclear cells from acute myeloid leukemia patients
    • Authors: Pogosova-Agadjanyan, E.L., Hua, X., Othus, M., Meshinchi, S., Stirewalt, D.L.
    • Year: 2023
    • Journal: Biomarker Research
    • Volume: 11
    • Issue: 1
    • Page: 31
    • Citations: 0
  2. Examining the impact of age on the prognostic value of ELN-2017 and ELN-2022 acute myeloid leukemia risk stratifications: a report from the SWOG Cancer Research Network
    • Authors: Termini, C.M., Moseley, A., Othus, M., Meshinchi, S., Stirewalt, D.L.
    • Year: 2023
    • Journal: Haematologica
    • Volume: 108
    • Issue: 11
    • Pages: 3148–3151
    • Citations: 2
  3. Coordinated missplicing of TMEM14C and ABCB7 causes ring sideroblast formation in SF3B1-mutant myelodysplastic syndrome
    • Authors: Clough, C.A., Pangallo, J., Sarchi, M., Bradley, R.K., Doulatov, S.
    • Year: 2022
    • Journal: Blood
    • Volume: 139
    • Issue: 13
    • Pages: 2038–2049
    • Citations: 44
  4. AML risk stratification models utilizing ELN-2017 guidelines and additional prognostic factors: A SWOG report
    • Authors: Pogosova-Agadjanyan, E.L., Moseley, A., Othus, M., Meshinchi, S., Stirewalt, D.L.
    • Year: 2020
    • Journal: Biomarker Research
    • Volume: 8
    • Issue: 1
    • Page: 29
    • Citations: 23

 

 

Jamal Shah | Biological Sciences | Best Researcher Award

Published on by WSA Awards

Dr. Jamal Shah | Biological Sciences | Best Researcher Award

Leturer, Abdul Wali Khan University Mardan, Pakistan

Dr. Jamal Shah is an accomplished educator and researcher specializing in agricultural economics. With a robust academic foundation and diverse teaching experience, he is dedicated to enhancing the understanding of economic principles within the agricultural sector. His research focuses on risk management strategies for farmers and the economic factors influencing crop production, contributing valuable insights for policy improvements in Pakistan’s agricultural landscape.

Professional Profile

Scopus Profile

Education

Dr. Jamal Shah completed his PhD in Economic Studies at the University of Dundee, Scotland, from 2016 to 2022. He also holds a Diploma in Agribusiness and Technology from Muscatine Community College, Iowa, USA (2012-2013). Additionally, Dr. Shah earned both his MSc (Hons) and BSc (Hons) in Agricultural Economics from Agricultural University Peshawar, Pakistan, completing his studies there in 2022.

Professional Experience

Dr. Shah is currently a lecturer at Abdul Wali Khan University Mardan (AWKUM), where he has been since September 2022, following a previous role as a lecturer from June 2015 to July 2016. At AWKUM, he has taken on significant responsibilities, including the analysis of economic trends and the development of comprehensive course materials for teaching advanced econometrics to PhD students. He has also supervised and guided various students in their research projects. Prior to this, he worked as an Economics Tutor at the University of Dundee and the International College Dundee, where he developed engaging tutorials and collaborated on curriculum development.

Research Interests

Dr. Shah’s research interests lie in agricultural economics, specifically focusing on risk management strategies among farmers and the economic dynamics of crop production. His work aims to provide insights that can influence agricultural policies and practices.

Research Projects 

PhD Research: His doctoral dissertation, titled “Factors Affecting Farmers’ Choice to Adopt Risk Management Strategies at Farm Level in Pakistan,” utilized various econometric models to explore the influences on farmers’ decisions regarding risk management. The findings are intended to inform policy development and implementation in agricultural risk management.

MSc Research: For his Master’s research, he conducted a comprehensive study titled “The Economics of Wheat Production in District Peshawar.” This project involved analyzing the key factors affecting wheat productivity using econometric methods, with implications for agricultural efficiency and policy enhancements.

Publications Top Notes

Optimizing performance: Achieving high capacitance and cycling durability in alkaline electrolyte with SnO2/SnSe||AC/KOH-based aqueous hybrid supercapacitor

Authors: Shah, M.Z.U., Shah, J., Hayat, K., Al-Saeedi, S.I., Shah, A.

Year: 2024

Journal: Journal of Energy Storage

Volume: 75

Article Number: 109662

Citations: 4

Conventional and Metal Oxide-Based Inverted Polymer Solar Cells: A Comparative Experimental Study

Authors: Shah, S.K., Ahmad, I., Shah, J., Haq, T., Hayat, K.

Year: 2023

Journal: Journal of Electronic Materials

Volume: 52

Issue: 2

Pages: 1400–1409

Citations: 2

Facile hydrothermal synthesis of zinc sulfide nanowires for high-performance asymmetric supercapacitor

Authors: Rauf, M., Shah, S.S., Shah, S.K., Aziz, M.A., Hayat, K.

Year: 2022

Journal: Journal of Saudi Chemical Society

Volume: 26

Issue: 4

Article Number: 101514

Citations: 46

Conclusion

Based on his academic achievements, research output, and technical skills, Dr. Shah demonstrates the qualities of a dedicated and skilled researcher. His contributions align well with the goals of a “Best Researcher Award,” recognizing individuals who produce research with broad applications and societal relevance.

 

 

 

 

 

 

Bibiana Doris Riquelme | Biomedical Physics | Best Researcher Award

Published on by WSA Awards

Bibiana Doris Riquelme | Biomedical Physics | Best Researcher Award

Principal Research, Consejo Investigaciones Universidad Nacional de Rosario (CIUNR), Argentina.

Bibiana Doris Riquelme is a distinguished physicist based in Rosario, Argentina, with extensive expertise in applied physics, biophotonics, hemorrheology, and biosensors. Her interdisciplinary approach combines principles of physical sciences and biomedical research, leading to significant advancements in understanding biomolecular interactions and their applications in medical technology. Riquelme is affiliated with the Institute of Physics of Rosario (IFIR), where she continues to contribute to innovative research initiatives.

Profile:

 

Education

Riquelme completed her Bachelor’s Degree in Physics from the National University of Rosario (UNR) in December 1989, specializing in applied optics to biology. She further advanced her education by earning a Doctorate in Physics in May 1997, focusing on the complex rheology of biomembranes and its application to human erythrocytes. Additionally, she holds a degree as a Professor of Drawing and Painting from S.S.M. Cosmopolita, demonstrating her diverse academic background and creative skills.

Professional Experiences

Bibiana Riquelme’s professional journey includes a postdoctoral fellowship awarded by FOMEC at the National University of Rosario, where she spent ten months abroad in France, engaged in research at the Laboratory of Mechanics and Cellular and Tissue Engineering. Her work in various esteemed institutions has allowed her to collaborate with leading researchers and contribute to significant advancements in her field. Currently, she is a research scientist at the Institute of Physics of Rosario, where she leads projects focusing on optics and biophysics.

 

Research skills

Riquelme possesses a comprehensive skill set in several critical areas of research, including optics, biophotonics, and hemorrheology. Her proficiency extends to the design and development of biosensors and the study of biomolecular interactions in solution. Her expertise in applied optics to biomedical sciences enables her to contribute significantly to both theoretical and practical advancements in health-related technologies, including medical biomaterials and stem cell technologies.

 

Awards And Recoginition

Throughout her career, Riquelme has received recognition for her contributions to science and technology. Her postdoctoral research experience and collaborations with international research institutions highlight her commitment to advancing knowledge in her field. While specific awards and recognitions are not detailed in the provided information, her standing as a researcher in the academic community reflects her impactful work and dedication to scientific excellence.

Conclusion

Bibiana Doris Riquelme possesses a robust academic background, specialized research expertise, and postdoctoral experience, making her a strong candidate for the Best Researcher Award. Her contributions to applied physics in the biomedical field and her potential for impactful research underscore her suitability for this recognition. Addressing the areas for improvement, particularly in showcasing her publications and community engagement, could further bolster her candidacy and demonstrate her influence within the scientific community.

Publication Top Notes

  • Preliminary Study of the Gamma-Radiation Effect on the Plasma Ions Concentration in Transfusion Units
    Authors: Alet, A.I., Porini, S., Detarsio, G., Galassi, M.E., Riquelme, B.D.
    Year: 2024
    Citation: Anales de la Asociacion Fisica Argentina, 35(1), pp. 21–24.
    🧪📊
  • Effect of Aqueous Extracts of Phyllanthus sellowianus on the Viscoelastic Properties of Human Red Blood Cells: In Vitro Antidiabetic Activity
    Authors: Mascaro Grosso, H., Buszniez, P., Castellini, H.V., Riquelme, B.D.
    Year: 2023
    Citation: Anales de la Asociacion Fisica Argentina, 34(2), pp. 42–45.
    🍃💉
  • Biospeckle Laser as a Tool to Analyze Erythrocyte Aggregation
    Authors: Toderi, M.A., Riquelme, B.D., Galizzi, G.E.
    Year: 2022
    Citation: Optical Engineering, 61(12), 124101.
    🔬✨
  • Methods: A New Protocol for In Vitro Red Blood Cell Glycation
    Authors: Batista da Silva, M.V., Alet, A.I., Castellini, H.V., Riquelme, B.D.
    Year: 2022
    Citation: Comparative Biochemistry and Physiology – Part A: Molecular and Integrative Physiology, 264, 111109.
    📚🧬
  • New Insights into the Mechanics of Erythrocytes: Effects of Radiation and Several Drugs of Biomedical Interest
    Authors: Riquelme, B.D., Toderi, M., Batista, M., Estrada, E., Alet, A.I.
    Year: 2022
    Citation: Series on Biomechanics, 36(1), pp. 61–69.
    🩸🔍
  • In Vitro Alteration on Erythrocytes Mechanical Properties by Propofol, Remifentanil, and Vecuronium
    Authors: Alet, A.I., Batista da Silva, M.V., Castellini, H.V., Alet, N.A., Riquelme, B.D.
    Year: 2021
    Citation: Microvascular Research, 135, 104132.
    💊🩹
  • New Insights into the Analysis of Red Blood Cells from Leukemia and Anemia Patients: Nonlinear Quantifiers, Fractal Mathematics, and Wavelet Transform
    Authors: Bortolato, S.A., Mancilla Canales, M.A., Riquelme, B.D., Ponce de León, P., Korol, A.M.
    Year: 2021
    Citation: Physica A: Statistical Mechanics and its Applications, 567, 125645.
    📈💔
  • Simultaneous Determination of Human Erythrocyte Deformability and Adhesion Energy: A Novel Approach Using a Microfluidic Chamber and the “Glass Effect”
    Authors: Londero, C.M., Riquelme, B.D.
    Year: 2021
    Citation: Cell Biochemistry and Biophysics, 79(1), pp. 49–55.
    🔬💧
  • Preliminary Study of the Effects of Gamma Radiations on Human Red Blood Cells
    Authors: Estrada, E., Castellini, H., Acosta, A., Riquelme, B.D., Galassi, M.E.
    Year: 2020
    Citation: Anales de la Asociacion Fisica Argentina, 31(2), pp. 51–54.
    ☢️🔴
  • Extensive Clinical, Serologic and Molecular Studies Lead to the First Reported Rhmod Phenotype in Argentina
    Authors: Mufarrege, N., Franco, N., Trucco Boggione, C., Castilho, L., Cotorruelo, C.
    Year: 2020
    Citation: Transfusion, 60(7), pp. 1373–1377.
    🩸🇦🇷

Mrinal Ghosh | Cancer Biology | Best Researcher Award

Published on by WSA Awards

Prof. Mrinal Ghosh | Cancer Biology | Best Researcher Award

Chief Scientist at CSIR-Indian Institute of Chemical Biology, India

Dr. Mrinal K. Ghosh is a distinguished Chief Scientist at the CSIR-Indian Institute of Chemical Biology and a Professor at AcSIR, New Delhi. With a Ph.D. in Biochemistry from the University of Calcutta, Dr. Ghosh specializes in cancer biology and inflammatory disorders. His extensive career includes leadership roles at CSIR-IICB and significant contributions to cancer research, particularly in glioma and breast cancer therapies. He has secured substantial funding for projects focusing on novel nanotechnology-based treatments and peptide therapeutics. Dr. Ghosh’s work has earned him prestigious awards such as the Bharat Vikash Award and recognition as a Fellow of the National Academy of Science & Technology. He is an active member of various scientific societies and has a robust publication record in high-impact journals. His research integrates advanced molecular biology techniques and translational medicine to address critical challenges in oncology.

Profile

Education

Dr. Mrinal K. Ghosh completed his education with a strong foundation in biochemistry and molecular biology. He earned his Ph.D. in Biochemistry from the University of Calcutta, India, where he conducted extensive research in the field from 1991 to 1997. Prior to his doctoral studies, Dr. Ghosh obtained his Master of Science degree in Biochemistry, with a focus on Molecular Biology, from the same institution in 1990. His undergraduate studies were in Chemistry, with honors, complemented by Physics and Mathematics, also at the University of Calcutta, culminating in his Bachelor of Science degree in 1988. Dr. Ghosh’s academic journey laid a solid groundwork for his subsequent research and leadership roles in cancer biology and inflammatory disorders, significantly contributing to his reputation as a leading scientist in his field.

Professional Experience

Dr. Mrinal K. Ghosh is a distinguished scientist with a remarkable career in cancer biology and inflammatory disorders. Currently serving as the Chief Scientist and Head of the Cancer Biology & Inflammatory Disorder Division at CSIR-Indian Institute of Chemical Biology (CSIR-IICB), he has been instrumental in advancing research in these fields. Prior to this role, he held positions as Senior Principal Scientist and Principal Scientist at CSIR-IICB, showcasing a trajectory of increasing responsibility. His earlier career included roles as Senior Lecturer at the Department of Biotechnology, HIT, Kolkata, and research positions at the Cleveland Clinic Foundation in the USA. Dr. Ghosh’s extensive experience includes leading significant research projects, managing research teams, and contributing to scientific advancements through his various roles and memberships in professional societies. His career is marked by his dedication to translating scientific discoveries into therapeutic innovations.

Research Interest

Dr. Mrinal K. Ghosh’s research interests focus on advancing cancer biology and inflammatory disorders through innovative biochemical and molecular approaches. His work emphasizes understanding the molecular mechanisms underlying cancer progression, particularly in glioma and breast cancer. Dr. Ghosh investigates the roles of key proteins and signaling pathways, including the p53 and Rb tumor suppressor proteins, and the ubiquitin-proteasome system in regulating cancer cell behavior. His research integrates nanotechnology and peptide therapeutics to develop novel treatment strategies, aiming to enhance the effectiveness of current therapies and overcome resistance. Additionally, Dr. Ghosh explores the implications of cancer biology in the context of stem cell research and neurodegenerative diseases. His comprehensive approach combines preclinical validation, clinical insights, and cutting-edge technology to address critical challenges in cancer treatment and provide new avenues for therapeutic interventions.

Research Skills

Dr. Mrinal K. Ghosh demonstrates exceptional research skills in the field of cancer biology and inflammatory disorders. His expertise spans molecular and cellular mechanisms, particularly in signal transduction related to cancer and stem cells. Dr. Ghosh is proficient in advanced techniques such as nanotechnology-based therapeutic systems, biomolecular target identification, and peptide therapeutic design. His research includes pre-clinical validation of therapies, focusing on glioma and breast cancer, utilizing sophisticated methods like protein modification and nanoparticle-based delivery systems. Dr. Ghosh’s ability to lead large-scale, multi-disciplinary projects is evident from his successful management of significant research grants and collaborations. His extensive publication record in high-impact journals and his role as a reviewer for leading scientific journals highlight his critical analytical skills and contribution to the scientific community. His innovative approach and comprehensive understanding of cancer biology underscore his research prowess.

Award and Recognition

Dr. Mrinal K. Ghosh has garnered significant recognition for his pioneering research in cancer biology and inflammatory disorders. His contributions have been acknowledged through numerous prestigious awards, including the Bharat Vikash Award in 2019, which honors outstanding achievements in scientific research. Dr. Ghosh is also a Fellow of the National Academy of Science & Technology (FNASc) and the Academy of Science & Technology (FAScT), reflecting his esteemed status within the scientific community. His research excellence is further underscored by his role as the Principal Investigator in several high-impact projects, such as the PAN-CSIR Cancer Research initiative and various DST-Nano Mission projects. Additionally, Dr. Ghosh has been honored with the Outstanding Scientist Award on Strategic Management and Business Strategy in 2023. These accolades, coupled with his extensive contributions to scientific literature and research, solidify his standing as a leading figure in his field.

Conclusion

Dr. Mrinal K. Ghosh is highly deserving of the Best Researcher Award due to his outstanding contributions to cancer biology and inflammatory disorders, as evidenced by his awards, extensive research funding, and high-impact publications. His leadership roles and recognition in the scientific community further underscore his excellence. Addressing areas such as enhancing international collaborations and increasing public engagement could further amplify his impact and align with broader scientific and societal goals.

Publications Top Notes

  1. MGMT in TMZ-based Glioma therapy: Multifaceted Insights and Clinical Trial Perspectives
    • Authors: Shaw R, Basu M, Karmakar S, Ghosh MK*
    • Journal: BBA – Molecular Cell Research
    • Year: 2024
    • Volume and Issue: 1871, 119673
    • Impact Factor: 5.1
    • Citations: 0
  2. Chromosomal instability (CIN) triggers immune evasion and metastatic potential in cancer through rewired STING signalling
    • Authors: Ghosh MK*, Roy S
    • Journal: Molecular Biomedicine
    • Year: 2024
    • Volume and Issue: 5(4)
    • Impact Factor: 6.0
    • Citations: 0
  3. E3 Ubiquitin Ligases in Lung Cancer: Emerging Insights and Therapeutic Opportunities
    • Authors: Basu B, Kal S, Karmakar S, Basu M, Ghosh MK*
    • Journal: Life Sciences
    • Year: 2024
    • Volume and Issue: 336, 122333
    • Impact Factor: 6.1
    • Citations: 0
  4. Carbon Nanotubes in Cancer Diagnosis and Treatment: Current Trends and Future Perspectives
    • Authors: Kumar S#, Ansari A#, Basu M#, Ghosh S#, Begam S#, Ghosh MK#*
    • Journal: Advanced Therapeutics
    • Year: 2024
    • Impact Factor: 4.6
    • Citations: 0
    • Status: In press
  5. E3 ubiquitin ligases and deubiquitinases in colorectal cancer: Emerging molecular insights and therapeutic opportunities
    • Authors: Kumar S, Basu M, Ghosh MK*
    • Journal: BBA – Molecular Cell Research
    • Year: 2024
    • Volume and Issue: 1871, 119673
    • Impact Factor: 5.1
    • Citations: 0
    • Status: In press
  6. Glioma Immunotherapy: Exploring Molecular and Clinical Frontiers
    • Authors: Ghosh MK*, Kumar S, Begam S, Ghosh S, Basu M
    • Journal: Life Sciences
    • Year: 2024
    • Impact Factor: 5.2
    • Citations: 0
    • Status: In press
  7. Glioma nanotherapy: Unleashing the synergy of dual-loaded DIM and TMZ
    • Authors: Sarkar S#, Kumar S#, Saha G, Basu M, Ghosh MK*
    • Journal: International Journal of Pharmaceutics
    • Year: 2024
    • Impact Factor: 5.3
    • Citations: 0
    • Status: Under Review (R1)
  8. Unraveling COVID-19 diagnostics: A roadmap for future pandemic
    • Authors: Kumar S, Basu M*, Chakraborty D, Ghosh P, Bajoria S, Ghosh MK*
    • Journal: Nature Cell & Sciences
    • Year: 2024
    • Status: Under Review

2023 Publications:

  1. USP7 – A crucial regulator of Cancer Hallmarks
    • Authors: Saha G, Roy S, Basu M, Ghosh MK*
    • Journal: BBA – Reviews on Cancer
    • Year: 2023
    • Volume and Issue: 1878, 188903
    • Impact Factor: 11.2
    • Citations: 10
  2. Neurological damages in COVID-19 patients: mechanisms and preventive interventions
    • Authors: Sarkar S#, Karmakar S#, Basu M, Ghosh P, Ghosh MK*
    • Journal: MedComm
    • Year: 2023
    • Volume and Issue: 4, e247,1-25
    • Impact Factor: 10.7
    • Citations: 10

 

Mahdieh Mondanizadeh | Molecular Medicine | Best Researcher Award

Published on by WSA Awards

Dr. Mahdieh Mondanizadeh | Molecular Medicine | Best Researcher Award

Department of Biotechnology and Molecular Medicine, Faculty of Medicine, Arak University of Medical Sciences, Arak, Iran.

Dr. Mahdieh Mondanizadeh is an Associate Professor of Molecular Medicine at Arak University of Medical Sciences, Iran. With a Ph.D. in Medical Molecular Medicine from Hamedan University of Medical Sciences, her research focuses on the role of microRNAs in cancer diagnosis, treatment, and neurological disorders. Dr. Mondanizadeh has led numerous research projects and thesis works, contributing significantly to the understanding of miRNAs in various diseases, including gastric cancer, glioma, and spinal cord injuries. Her work is widely published in esteemed journals, highlighting her expertise in molecular biology and her commitment to advancing medical science. Dr. Mondanizadeh’s research has practical implications, such as the development of non-invasive diagnostic methods for cancer and the exploration of targeted therapies. Her international exposure, including a visit to the University of Adelaide, further underscores her global perspective and dedication to collaborative research.

Profile
Education

Dr. Mahdieh Mondanizadeh is a highly qualified academic and researcher in the field of molecular medicine. She earned her Ph.D. in Medical Molecular Medicine from Hamedan University of Medical Sciences, Hamedan, Iran, where she conducted significant research from 2010 to 2014. Her doctoral thesis focused on evaluating the effect of miR-124 on transcription factors involved in the proliferation and differentiation of neuronal cells. Prior to her Ph.D., Dr. Mondanizadeh completed her M.Sc. in Medical Microbiology at Qom Islamic Azad University, Qom, Iran, from 2005 to 2007, further solidifying her foundation in microbiological research. She also holds a B.Sc. in Microbiology from Arak Azad University, Arak, Iran, which she completed between 2000 and 2004. In 2012, Dr. Mondanizadeh expanded her expertise through a visitorship at the University of Adelaide, Australia, enriching her research experience and international collaboration skills.

Professional Experience

Dr. Mahdieh Mondanizadeh is an Associate Professor of Molecular Medicine at the Department of Biotechnology, Arak University of Medical Sciences, Iran. Since joining the institution in 2015, she has made significant contributions to the field of molecular medicine, focusing on the role of microRNAs in cancer diagnosis and treatment. Dr. Mondanizadeh has successfully led numerous research projects, including the development of novel diagnostic assays and the investigation of miRNA-related gene expression in various diseases. Her expertise extends to the study of molecular pathways in cancer, spinal cord injuries, and neurodegenerative diseases. Additionally, she has collaborated with international researchers and published extensively in high-impact journals. Her work is recognized for its innovation and potential to influence future medical treatments, making her a respected figure in the scientific community.

Research Interest

Mahdieh Mondanizadeh’s research interests are deeply rooted in molecular medicine, with a particular focus on the role of microRNAs (miRNAs) in various human diseases. Her work extensively explores the regulatory functions of miRNAs in cancer, neurological disorders, and infectious diseases, aiming to uncover their potential as diagnostic biomarkers and therapeutic targets. Mondanizadeh is especially interested in the molecular mechanisms underlying cancer progression, including the role of miRNAs in signal transduction pathways and gene expression regulation. Her research also extends to the study of miRNA involvement in spinal cord injuries, neurodegenerative diseases, and reproductive health issues. Additionally, she investigates the therapeutic potential of natural compounds and their effects on miRNA expression and cancer treatment. Through her research, Mondanizadeh contributes to the development of novel diagnostic tools and targeted therapies, advancing the field of personalized medicine.

Research Skills

Mahdieh Mondanizadeh is a highly skilled researcher with extensive expertise in molecular medicine and microbiology. Her research skills are demonstrated through her successful management of numerous projects focused on the role of microRNAs in cancer, neurodegenerative diseases, and infectious diseases. She excels in designing and conducting complex experiments, particularly those involving gene expression analysis, miRNA profiling, and the development of diagnostic assays. Her proficiency in molecular techniques such as real-time PCR, immunohistochemistry, and cell culture is complemented by her strong analytical abilities, allowing her to interpret data with precision and contribute to high-impact publications. Additionally, her collaborative approach and leadership in multidisciplinary research projects highlight her ability to integrate various scientific disciplines. Mondanizadeh’s commitment to advancing molecular medicine is further evidenced by her active participation in grant writing and project management, ensuring the successful completion and dissemination of her research findings.

Awards and Recognition

Dr. Mahdieh Mondanizadeh has garnered significant recognition for her impactful contributions to the field of molecular medicine and biotechnology. As an Associate Professor at Arak University of Medical Sciences, she has received multiple research grants and led numerous projects focusing on the role of microRNAs in various diseases, particularly cancer. Her innovative work in non-invasive cancer diagnostics and therapeutic strategies has earned her acclaim both nationally and internationally. Dr. Mondanizadeh has published extensively in high-impact journals, highlighting her research excellence and commitment to advancing medical science. She has also been invited to present her findings at prestigious conferences, further cementing her reputation as a leading researcher in her field. Her dedication to mentoring students and fostering a collaborative research environment has also been recognized, making her a respected figure in the academic community.

Conclusion

Mahdieh Mondanizadeh is a strong candidate for the Best Researcher Award due to her extensive research achievements, leadership in scientific projects, and significant contributions to the understanding of molecular mechanisms in disease. Enhancing the application and impact of her research findings and expanding her international collaborations could further bolster her candidacy. Overall, her work positions her as a deserving contender for this prestigious recognition.

Publications Top Notes

  1. MiRNAs related in signaling pathways of women’s reproductive diseases: an overview
    • Authors: M. Bagheri, B. Khansarinejad, M. Mondanizadeh, M. Azimi, S. Alavi
    • Year: 2024
  2. A systems biology approach and in vitro experiment indicated Rapamycin targets key cancer and cell cycle-related genes and miRNAs in triple-negative breast cancer cells
    • Authors: A. Tafti, S. Shojaei, H. Zali, S. Mohammadi-Yeganeh, M. Mondanizadeh
    • Year: 2023
    • Citations: 2
  3. Assessment of efficacy of carboxytherapy in management of skin aging through evaluation of gene expression profile: a 2-split randomized clinical trial
    • Authors: N. Bagherani, A. Firooz, A. Ghanadan, M. Mondanizadeh, G. Tavoosidana
    • Year: 2023
  4. Hsa-miR-15b-5p/miR-195-5p Controls Osteogenic Differentiation of Human Adipose-Derived Mesenchymal Stem Cells Through Regulating Indian Hedgehog Expression
    • Authors: S. Harimi, B. Khansarinejad, F. Fesahat, M. Mondanizadeh
    • Year: 2023
  5. Optimizing a Calorimetric Method for Quantitative Assessment of Alkaline Phosphatase to confirm the Osteogenic Differentiation of Mesenchymal Stem Cell
    • Authors: S. Harimi, F. Zare, F. Fesahat, M. Mondanizadeh
    • Year: 2023
  6. The role of microRNAs in diseases and related signaling pathways
    • Authors: A. Vaghf, B. Khansarinejad, E. Ghaznavi-Rad, M. Mondanizadeh
    • Year: 2022
    • Citations: 9
  7. Low Frequency of Adenovirus, Rotavirus, and Norovirus in Pediatric Diarrheal Samples from Central Iran
    • Authors: E. Abbasi, M. Mondanizadeh, A. van Belkum, E. Ghaznavi-Rad
    • Year: 2022
    • Citations: 3
  8. The role of miRNAs as a big master regulator of signaling pathways involved in lymphoblastic leukemia
    • Authors: M. Bagheri, P.Z. Sarabi, M. Mondanizadeh
    • Year: 2022
    • Citations: 3
  9. A Review of the Function of Circulating Cell Free miRNAs as Promising Biomarkers in Cancer Diagnosis, Treatment, and Metastasis
    • Authors: M. Zand, M. Mondanizadeh
    • Year: 2022
  10. Pap Smear miR-92a-5p and miR-155-5p as Potential Diagnostic Biomarkers of Squamous Intraepithelial Cervical Cancer
    • Authors: T. Azimi, M. Paryan, M. Mondanizadeh, H. Sarmadian, A. Zamani
    • Year: 2021
    • Citations: 8